tiprankstipranks
Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
US Market
Want to see APGE full AI Analyst Report?

Apogee Therapeutics (APGE) Blogger Opinions & Sentiment

366 Followers

Blogger Sentiment

Bearish: 75.00%
Sector Average
Neutral
APGE Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
25% SeekingAlpha
25% GuruFocus
25% Zacks
25% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

AbbVie Stock Dips 4.4% Despite Robust Q2: Buy the Dip or Stay Cautious?
Zacks
FMR LLC Significantly Reduces Stake in Apogee Therapeutics Inc.
GuruFocus
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Apogee Therapeutics: 'Strong Buy' As Zumilokibart Progresses To Next Q2 Milestone
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of APGE?
Seeking Alpha’s Terry Chrisomalis has a Bullish Sentiment.
    What do Motley Fool contributors think of APGE?
    Currently there's no blogger sentiment for APGE.
    What Is APGE’s Blogger Sentiment?
    APGE’s Blogger Sentiment is Neutral.
      What was the most recent blogger prediction for APGE?
      The most recent blogger prediction for APGE was made by Kinjel Shah, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          CLVLFClinuvel Pharmaceuticals
          ZVRAZevra Therapeutics
          SMMTSummit Therapeutics